SEC Form SC 13G/A filed by Hologic, Inc. (Amendment)

9/10/21 9:33:54 AM ET

Medical Electronics

Health Care

Get the next $HOLX alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No. 3 HOLOGIC INC COMMON STOCK Cusip #436440101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #436440101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,301,237 Item 6: 0 Item 7: 13,258,141 Item 8: 0 Item 9: 13,258,141 Item 11: 5.230% Item 12: HC Cusip #436440101 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 13,258,141 Item 8: 0 Item 9: 13,258,141 Item 11: 5.230% Item 12: IN Item 1(a). Name of Issuer: HOLOGIC INC Item 1(b). Address of Issuer's Principal Executive Offices: 250 Campus Drive Marlborough, MA 01752 US Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 436440101 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 13,258,141 (b) Percent of Class: 5.230% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,301,237 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 13,258,141 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of HOLOGIC INC. No one other person's interest in the COMMON STOCK of HOLOGIC INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 9, 2021 Date /s/ Kevin M. Meagher Signature Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC IA Fidelity Management Trust Company BK Strategic Advisers LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act ("Fidelity Funds") advised by Fidelity Management & Research Company LLC ("FMR Co. LLC"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. FMR Co. LLC carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on September 9, 2021, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of HOLOGIC INC at August 31, 2021. FMR LLC By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 30, 2018, by and on behalf of Abigail P. Johnson* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414.

Get the next $HOLX alert in real time by email

Date	Price Target	Rating	Analyst
5/27/2025		Hold	Needham
3/3/2025		Buy → Hold	Argus
2/6/2025	$80.00 → $75.00	Outperform → Market Perform	Leerink Partners
2/3/2025		Buy → Hold	Needham
12/13/2024		Peer Perform	Wolfe Research
12/10/2024	$90.00	Buy	Needham
12/10/2024	$85.00	Hold	Jefferies
10/1/2024	$95.00 → $85.00	Buy → Neutral	Citigroup

SEC Form SC 13G/A filed by Hologic, Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for $HOLX

$HOLX FDA approvals

Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

October 29, 2024 - FDA Roundup: October 29, 2024

February 2, 2024 - FDA Roundup: February 2, 2024

$HOLX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

New insider Liddy Anne M. claimed ownership of 11,426 shares (SEC Form 3)

Director Mcmillan Wayde D. was granted 1,742 shares (SEC Form 4)

$HOLX Financials

Live finance-specific insights

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Hologic Announces Financial Results for First Quarter of Fiscal 2025

$HOLX SEC Filings

SEC Form SD filed by Hologic Inc.

SEC Form 10-Q filed by Hologic Inc.

Hologic Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$HOLX Press Releases

Fastest customizable press release news feed in the world

$HOLX Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$HOLX Leadership Updates

Live Leadership Updates

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Needham reiterated coverage on Hologic

Hologic downgraded by Argus

Hologic downgraded by Leerink Partners with a new price target

Biote Announces CEO Retirement and Succession Plan

CellMax Life Announces Expansion of Company Board With Leading Industry Experts

IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

$HOLX Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Hologic Inc.

SEC Form SC 13G filed by Hologic Inc.

SEC Form SC 13G/A filed by Hologic Inc. (Amendment)

$HOLX Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

Recent Analyst Ratings for
$HOLX

$HOLX
FDA approvals

$HOLX
Insider Trading

$HOLX
Financials

$HOLX
SEC Filings

$HOLX
Press Releases

$HOLX
Analyst Ratings

$HOLX
Leadership Updates

$HOLX
Large Ownership Changes

$HOLX
Insider Purchases